Feeling stressed about finances? You're not alone. Economic hardships can make managing money feel overwhelming. But there's good news! By assessing your finances and creating a plan to achieve your goals, you can reduce stress and boost your financial wellbeing.
Our Employee and Family Assistance Program (EFAP) provides numerous resources on the WorkHealthLife website. Search "The United Church of Canada" to gain access to articles and resources, such as:
Money and your mind: taking care of your finances and mental health
Financial health: how your finances affect your mind
Millennials: Your financial future is now
Mental Health Awareness Month
May is also Mental Health Awareness Month, a perfect time to focus on your overall wellbeing. Here are some important dates to keep in mind:
Let's make May a month of empowerment and positive change!
As we approach the end of the year, it's the perfect time to reflect on our health and well-being. Teladoc Medical Experts is here to support you with a range of unique medical services designed to provide peace of mind and expert guidance. Stay healthy and informed this December with Teladoc's newsletter.
Expert Medical Opinion
Have you ever felt uncertain about a diagnosis or treatment plan? With Teladoc's Expert Medical Opinion service, you can receive an evaluation of your diagnosis and treatment plan from a carefully selected expert. This ensures you have the confidence and clarity needed to make informed decisions about your health.
Personal Health Navigator
Navigating the healthcare system can be overwhelming. The Personal Health Navigator service empowers you to make informed decisions about your care. Whether you need help understanding your options or connecting to valuable resources, their navigators are there to guide you every step of the way.
Finding a Doctor
Finding the right specialist can be challenging. Teladoc offers access to an extensive network of experts, ensuring you can find the specialist you need in your local area. Their network is designed to connect you with top-tier medical professionals who can address your specific health concerns.
Care Finder
For those seeking specialized care outside of Canada, the Care Finder service is invaluable. With a global database of over 50,000 expert physicians across more than 450 specialties and subspecialties, Teladoc can help you locate the right specialist no matter where you are.
You can access Teladoc Medical Experts by calling 1-877-419-2378 or visiting their website. You'll be connected to a Member Advocate, a Registered Nurse, who will assess your needs and provide the services designed to help you confidently move forward with your care.
As part of GreenShield’s commitment to delivering an exceptional member experience, they will be modernizing their compound policy. This will be implemented in several phases, focusing on specific reimbursement conditions and compound categories. Phase 1 is projected to be implemented on September 3, 2024.
Biosimilar transitioning British Columbia
In May 2019, the British Columbia (B.C.) government implemented a biosimilar switching policy under its public prescription drug insurance plan. In December 2023, BC PharmaCare announced it would provide a six-month transitional period to allow those using Humalog (insulin lispro), used to treat diabetes, with an Omnipod, Ypsomed, Tandem, or Medtronic pump to transition to the biosimilar, Admelog by May 30, 2024. Health Canada has approved Admelog for use with these pumps, and it is a regular PharmaCare benefit. Patients with new approvals for insulin pumps are expected to use Admelog. Details can be found on the BC PharmaCare website.
In accordance with provincial coordination policies, GreenShield will expand their standard Biosimilar Transition Program in British Columbia to include Humalog for those using an Omnipod, Ypsomed, Tandem, or Medtronic pump. Unless an exception applies, the program will transition on July 22, 2024.
GSC have notified plan members that they must transition to Admelog by July 22, 2024. Plan members claiming Humalog and coordinating benefits with the BC PharmaCare Drug Plan will receive letters advising them of the upcoming transition. They also recommend consulting with their prescriber for transitioning support, including obtaining a new prescription for Admelog, if necessary. However, if BC PharmaCare grants an exception to allow a plan member to remain on Humalog, GreenShield will follow suit and pay for Humalog to enable continued coordination of claims.
Biosimilar transitioning Quebec
In April 2022, the Government of Quebec implemented a biosimilar switching policy under its public prescription drug insurance plan. On December 12, 2023, Régie de l'assurance maladie du Québec (RAMQ) announced as of December 13, 2023, the biologic Lucentis (ranibizumab), used to treat various eye conditions, will no longer be listed on the List of Medications and RAMQ patients being treated with Lucentis were required to transition to the biosimilar, Byooviz by May 22, 2024. Details can be found on the Infolettre RAMQ (available only in French).
GreenShield will also expand their standard Biosimilar Transition Program in Quebec to include Lucentis. Unless an exception applies, the transition date will be August 22, 2024.
GSC have notified plan members that they must transition to Byooviz by August 22, 2024. Plan members claiming Lucentis (including those coordinating with another drug plan) will receive letters advising them of the upcoming transition. They also recommend consulting with their prescriber or pharmacist for transitioning support, including obtaining a new prescription for Byooviz, if necessary.
Per RAMQ criteria, exemptions will apply to:
If you have any questions, please contact Benefits@united-church.ca
GreenShield has advised that their union represented employees have voted in favour of a new, 3-year collective agreement with Green Shield Canada.
The GreenShield contact centre will reopen on Monday, April 22, however, it is anticipated that call volumes may be higher than usual at this time.
GreenShield continues to encourage members to use the fully operational online services, including Web, mobile, providerConnect and all real-time submissions from pharmacies and dental offices. For support checking your coverage online, please visit their self-service page.
GreenShield’s self-serve phone system is available via the call centre number, 1-888-711-1119, to:
If you have any questions, please email the Benefits Centre at Benefits@united-church.ca
GreenShield's collective agreement with Unifor expired on Friday, March 1, leading to a strike. GreenShield has activated its contingency plan to ensure essential services continue during the strike.
GreenShield remains optimistic that a settlement can be reached through constructive and focused discussions.
Online services, including claim submissions, continue to be available and are not impacted by the Unifor strike, and there will be no interruption to the health and administrative services that GreenShield provides.
The GreenShield contact centre is closed during the strike, but you will still be able to use GreenShield’s online services or their self-serve phone system depending on your needs. Since 94% of claims are submitted online, online service claims continue to be processed; other online services that most members rely on also remain available with minimal disruption.
GreenShield’s self-serve phone system is available via the call centre number, 1-888-711-1119, to:
GreenShield encourages members to use the fully operational online services, including Web, mobile, providerConnect and all real-time submissions from pharmacies and dental offices.
If you have any questions, please email the Benefits Centre at Benefits@united-church.ca
These are early days for the federal plan, so stay tuned for any changes. We’ve just recently been advised that people who opted out of an employer’s retiree health and dental benefit plan before December 11, 2023, and cannot opt back in under the plan rules, are eligible for the Canadian Dental Care Plan (CDCP). Anyone who chooses to opt out after this date will not be eligible.
The following is the eligibility criteria of the Canadian Dental Care Plan that was updated on March 4, 2024 on the Government of Canada website.
Eligibility criteria
To qualify for the CDCP, you must:
You need to meet all the eligibility criteria to qualify for the CDCP.
If you have any questions about eligibility for the Canadian Dental Care Plan, please email benefits@united-church.ca or call the Benefits Centre at 1-855-647-8222.
With new biologics entering the market rapidly, the overall cost of biologic drugs continues to significantly impact the sustainability of drug plans, including ours. GreenShield’s evidence-based biosimilar strategy combines innovative programs and approaches to ensure the best value for treatment, while optimizing resources, supporting the uptake of biosimilars, and improving access to medications for all plan members.
The originator biologic, Humira (adalimumab), continues to be one of the world’s top-selling drugs for more than two decades, treating a range of inflammatory conditions. Currently, eight approved adalimumab biosimilars in the Canadian market have all demonstrated similar safety and efficacy profiles to the originator, Humira.
Effective January 15, 2024, the following biosimilar products will be split into two categories: preferred and non-preferred products, as outlined in the table below. This means, anyone starting adalimumab therapy, effective January 15, 2024, must use a Category 1 (preferred product) below.
The choice of preferred products was evaluated based on several criteria including the formulation and format of the product, the robustness of the manufacturer’s patient co-pay assistance program, the quality of the patient support program, and the manufacturer’s track record of drug shortages. All three preferred products demonstrated excellence in these areas and maintain the opportunity for plan member choice.
Category 1 (preferred products) Abrilada, Hyrimoz, and Hadlima
Category 2 (non-preferred products)* Amgevita, Hulio, Idacio, Simlandi, and Yuflyma
The preferential listing applies to all Health Canada approved indications including:**
If a member under this program chooses to transition to an adalimumab biosimilar, they must select a Category 1 (preferred product) unless an exception applies.*
* Products listed as Category 2 agents will be non-preferred products and will only be available to patients in exceptional circumstances (e.g., documented intolerance or adverse events to 2 preferred products).
** Preferential listing does not apply in Quebec and will only apply where GreenShield is the primary payor.
This reminder is a follow-up to notices shared late last year and earlier this year with community of faith treasurers and administrators, as well as ministry personnel, about changes to the regional cost of living group assignments. A copy of the letter shared with treasurers and administrators is in the Downloads section at the bottom of the Ministers’ Salary Schedule and Cost of Living Groups webpage.
These changes will be effective for the pay period beginning July 1, 2023, and apply to the balance of the year. You can find the revised cost of living group assignment data in the Downloads section as well.
If your regional COL group assignment has moved up, your ADP administrator will need to update the minister’s salary in TeamPay or inform ADP of the new salary amount for the pay period beginning July 1.
Salaries for ministry personnel serving in locations where the regional COL group assignment has been adjusted down will be maintained as per the terms of the appointment or call. This includes those whose appointments renew. This means that if the pastoral charge is in a lower cost of living group, the current minister’s salary may not be reduced. It will remain subject to the annual economic adjustment to minimum salaries or as defined in the terms of appointment or call.
There is no change to the COL group for 45 percent of communities of faith. Thirty-nine percent of communities of faith have stepped up one group. Sixteen percent have stepped down one group. These changes reflect regional differences in the costs of housing, property and provincial income taxes, utilities, and goods and services.
Connex is your newsletter that provides information about your pension, benefits, and payroll. If you were previously receiving an email about Connex and didn’t see it in your inbox, check your spam folder! If it’s still not there and you would like to receive Connex, please sign up for the latest news and updates by filling out the form below.
The accrual rate is the rate at which you earn your pension. In 2023, you will earn your pension at the rate of 1.85% of your pensionable earnings.
You earn a piece of pension every year that you work and contribute to the plan―like building blocks.
For example, let’s assume that a member’s pensionable earnings stayed constant at $60,000 every year (for easy figuring). From 2019 to 2024, that member would earn:
| Year | Accrual Rate | Formula | Pension Credit Earned |
| 2019 | 1.4% | 1.4% of $60,000 | $ 840 |
| 2020 | 1.85% | 1.85% of $60,000 | $ 1,110 |
| 2021 | 1.625% | 1.625% of $60,000 | $ 975 |
| 2022 | 1.85% | 1.85% of $60,000 | $ 1,110 |
| 2023 | 1.85% | 1.85% of $60,000 | $ 1,110 |
| 2024 | 1.4% | 1.4% of $60,000 | $ 840 |
At the end of your career, the annual pension amounts earned each year (pension credits) will add up to the total annual pension you will receive every year for the rest of your life. So, the higher amount earned in 2023 will continue to benefit you for the rest of your retired life.
There is no automatic indexing or increases in our pension plan. Each year, the Pension Board and Pension Plan Advisory Committee assess the resources available and determine whether there are surplus funds that can be used to increase benefits.
